News Releases

June 15, 2020

ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California Read More »

February 11, 2020

ProSciento Appoints Dr. Michael Grimm as Chief Medical Officer Read More »

February 6, 2020

ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH) Read More »

See More »